By considering all prescriptions within a defined 100-day window around BMI events, this approach offers a broader view of prescribing trends among adolescents with obesity, allowing us to assess ongoing treatment patterns rather than just initial prescriptions
Some are FDA-approved to treat obesity (Wegovy, Saxenda), while others can be used off-label for weight loss (Mounjaro, Ozempic, Rybelsus, Victoza, Trulicity)
Here, the authors would like to thank Prof Nasrin Shokrpour at the Research Consultation Center (RCC) of Shiraz University of Medical Sciences for improving the use of English in the manuscript
Most people try to lose weight through conventional methods such as diet and exercise
Co-corresponding author and co-first author Fabio Hecht, PhD, and co-first author Marco Zocchi, PhD, led the study in the Harris lab in the Department of Biomedical Genetics